SE Brogan, JE Sindt, DW Odell, A Gulati… - Regional Anesthesia & …, 2023 - rapm.bmj.com
Pain and suffering related to cancer are challenging issues that continue to deserve consideration for treatment optimization. Advances in analgesic management and control of …
SE Brogan, DW Odell, JE Sindt, I Yi… - … : Technology at the …, 2023 - Elsevier
Objectives In the practice of intrathecal drug delivery, consensus exists regarding the cephalad to caudad location of the catheter tip relative to dermatomal distribution of pain …
TR Deer, SM Hayek, JS Grider, JE Pope… - … : Technology at the …, 2024 - Elsevier
Abstract Introduction The International Neuromodulation Society convened a multispecialty group of physicians based on expertise with international representation to establish …
A Mahmoud, MM Aman, JL Trumbo… - Journal of pain …, 2023 - Taylor & Francis
Objective Targeted drug delivery (TDD) via intrathecal drug delivery systems (IDDS) exposure and clinical adoption remains low despite multiple well-designed trials that …
W Wang, Q Shi, Y Cao, B Fan, Y Yang - Heliyon, 2024 - cell.com
Objective Intrathecal drug delivery systems (IDDS) have been clinically applied to treat refractory cancer-related pain for years. In this study, we demonstrate the current clinical …
X Li, Y Wang, D Zou, W Zhang, P He… - Zhong nan da xue …, 2024 - europepmc.org
Objectives The distribution characteristics of intrathecal drugs and the limitation of current catheterization techniques make traditional intrathecal analgesic treatment nearly useless …
P Papa, L Buela, H Prinzo - Revista Médica del Uruguay, 2024 - scielo.edu.uy
El control del dolor es uno de los desafíos más importantes en el ámbito de cuidados paliativos y tiene un profundo impacto en la calidad de vida de los pacientes. En la mayoría …
Introsuction: Itching is one of the main side effects of intrathecal opioids administration. In the present study, prevalence of itching following intrathecal fentanyl administration and its …